Stevanato Group S.p.A Revenue 2021-2025 | STVN

Stevanato Group S.p.A revenue from 2021 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Stevanato Group S.p.A Annual Revenue
(Millions of US $)
2025 $1,342
2024 $1,195
2023 $1,175
2022 $1,036
2021 $998
2020 $756
Stevanato Group S.p.A Quarterly Revenue
(Millions of US $)
2025-12-31 $400
2025-09-30 $354
2025-06-30 $318
2025-03-31 $270
2024-12-31 $353
2024-09-30 $306
2024-06-30 $280
2024-03-31 $256
2023-12-31 $345
2023-09-30 $295
2023-06-30 $278
2023-03-31 $255
2022-12-31 $302
2022-09-30 $247
2022-06-30 $249
2022-03-31 $238
2021-12-31 $267
2021-09-30 $253
2021-06-30 $246
2021-03-31 $232
2020-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $4.849B $1.195B
Stevanato Group S.p.A. is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. Stevanato Group S.p.A. is based in PIOMBINO DESE, Italy.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $100.311B 35.03
Takeda Pharmaceutical (TAK) Japan $58.739B 11.54
Zoetis (ZTS) United States $53.462B 19.73
BeOne Medicines - (ONC) Switzerland $37.951B 201.20
Sandoz Group AG (SDZNY) Switzerland $37.721B 0.00
Otsuka Holdings, - (OTSKY) $37.221B 0.00
Daiichi Sankyo, - (DSNKY) Japan $36.542B 0.00
United Therapeutics (UTHR) United States $20.394B 17.95
Shionogi (SGIOY) Japan $19.736B 15.26
Merck (MKKGY) Germany $19.561B 12.06
IPSEN (IPSEY) France $15.077B 0.00
Ionis Pharmaceuticals (IONS) United States $13.055B 0.00
Neurocrine Biosciences (NBIX) United States $12.457B 26.92
Summit Therapeutics (SMMT) United States $11.536B 0.00
Orion OYJ (ORINY) Finland $11.214B 19.47
Madrigal Pharmaceuticals (MDGL) United States $10.554B 0.00
Eisai (ESAIY) $9.636B 0.00
Ono Pharmaceutical (OPHLF) Japan $8.769B 20.98
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.828B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.659B 22.12
Crinetics Pharmaceuticals (CRNX) United States $4.363B 0.00
Indivior Pharmaceuticals (INDV) United States $4.323B 17.64
Corcept Therapeutics (CORT) United States $4.204B 45.42
NewAmsterdam Pharma (NAMS) Netherlands $3.927B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $3.322B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.990B 9.54
Hypermarcas (HYPMY) Brazil $2.658B 18.24
Dyne Therapeutics (DYN) United States $2.220B 0.00
Guardian Pharmacy Services (GRDN) United States $2.119B 40.81
Avadel Pharmaceuticals (AVDL) Ireland $2.113B 0.00
Soleno Therapeutics (SLNO) United States $2.000B 0.00
Ocular Therapeutix (OCUL) United States $1.933B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.876B 22.23
Harrow (HROW) United States $1.766B 108.39
Ardelyx (ARDX) United States $1.669B 0.00
Enliven Therapeutics (ELVN) United States $1.586B 0.00
Oruka Therapeutics (ORKA) United States $1.559B 0.00
Definium Therapeutics (DFTX) United States $1.552B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.551B 0.00
Relay Therapeutics (RLAY) United States $1.548B 0.00
Nektar Therapeutics (NKTR) United States $1.451B 0.00
Collegium Pharmaceutical (COLL) United States $1.447B 7.17
BioCryst Pharmaceuticals (BCRX) United States $1.425B 84.50
Evotec AG (EVO) Germany $1.248B 0.00
Savara (SVRA) United States $1.139B 0.00
Xeris Biopharma Holdings (XERS) United States $1.132B 0.00
Theravance Biopharma (TBPH) United States $0.990B 41.55
Cronos Group (CRON) Canada $0.988B 0.00
Aktis Oncology (AKTS) United States $0.900B 0.00
ARS Pharmaceuticals (SPRY) United States $0.875B 0.00
Xencor (XNCR) United States $0.828B 0.00
Esperion Therapeutics (ESPR) United States $0.820B 0.00
KalVista Pharmaceuticals (KALV) United States $0.754B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.732B 17.31
Bioventus (BVS) United States $0.684B 14.02
Rigel Pharmaceuticals (RIGL) United States $0.623B 5.56
ProKidney (PROK) United States $0.596B 0.00
Lyell Immunopharma (LYEL) United States $0.549B 0.00
4D Molecular Therapeutics (FDMT) United States $0.534B 0.00
Altimmune (ALT) United States $0.511B 0.00
Siga Technologies (SIGA) United States $0.486B 6.66
Zevra Therapeutics (ZVRA) United States $0.479B 0.00
Elite Pharmaceuticals (ELTP) United States $0.474B 0.00
Organogenesis (ORGO) United States $0.473B 0.00
Nature's Sunshine Products (NATR) United States $0.471B 28.03
Lexeo Therapeutics (LXEO) United States $0.461B 0.00
Aquestive Therapeutics (AQST) United States $0.445B 0.00
USANA Health Sciences (USNA) United States $0.382B 10.66
Aclaris Therapeutics (ACRS) United States $0.346B 0.00
Protara Therapeutics (TARA) United States $0.336B 0.00
Akebia Therapeutics (AKBA) United States $0.321B 0.00
Aldeyra Therapeutics (ALDX) United States $0.318B 0.00
Cybin (HELP) Canada $0.304B 0.00
Relmada Therapeutics (RLMD) United States $0.273B 0.00
Minerva Neurosciences (NERV) United States $0.271B 0.00
Avalo Therapeutics (AVTX) United States $0.264B 0.00
Enlivex Therapeutics (ENLV) Israel $0.263B 0.00
Larimar Therapeutics (LRMR) United States $0.261B 0.00
Journey Medical (DERM) United States $0.257B 0.00
OmniAb (OABI) United States $0.245B 0.00
Profound Medical (PROF) Canada $0.240B 0.00
Achieve Life Sciences (ACHV) Canada $0.224B 0.00
MediWound (MDWD) Israel $0.222B 0.00
Context Therapeutics (CNTX) United States $0.211B 0.00
Heron Therapeutics (HRTX) United States $0.211B 0.00
Silence Therapeutics (SLN) United Kingdom $0.210B 0.00
Surrozen (SRZN) United States $0.210B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.184B 0.00
Innate Pharma SA (IPHYF) France $0.181B 0.00
Galectin Therapeutics (GALT) United States $0.178B 0.00
AleAnna (ANNA) United States $0.171B 0.00
Karyopharm Therapeutics (KPTI) United States $0.157B 0.00
Century Therapeutics (IPSC) United States $0.153B 0.00
Prelude Therapeutics (PRLD) United States $0.140B 0.00
VAXART, INC (VXRT) United States $0.136B 0.00
Unicycive Therapeutics (UNCY) United States $0.133B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.133B 0.00
Avita Medical (RCEL) United States $0.127B 0.00
Inhibikase Therapeutics (IKT) United States $0.126B 0.00
Cardiol Therapeutics (CRDL) Canada $0.116B 0.00
Korro Bio (KRRO) United States $0.105B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
Incannex Healthcare (IXHL) Australia $0.093B 0.00
Vivani Medical (VANI) United States $0.092B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.091B 0.00
Champions Oncology (CSBR) United States $0.084B 35.76
Pyxis Oncology (PYXS) United States $0.081B 0.00
Assertio Holdings (ASRT) United States $0.079B 0.00
PolyPid (PYPD) Israel $0.070B 0.00
Gain Therapeutics (GANX) United States $0.070B 0.00
HST Global (HSTC) United States $0.069B 0.00
Rafael Holdings (RFL) United States $0.062B 0.00
PMV Pharmaceuticals (PMVP) United States $0.059B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.058B 48.50
Fractyl Health (GUTS) United States $0.057B 0.00
BioNxt Solutions (BNXTF) Canada $0.057B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.056B 0.00
Dominari Holdings (DOMH) United States $0.055B 0.00
NRx Pharmaceuticals (NRXP) United States $0.053B 0.00
Acrivon Therapeutics (ACRV) United States $0.051B 0.00
Nutriband (NTRB) United States $0.050B 0.00
Lipocine (LPCN) United States $0.048B 0.00
ElectroCore (ECOR) United States $0.043B 0.00
Lite Strategy (LITS) United States $0.041B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Plus Therapeutics (PSTV) United States $0.038B 0.00
Talphera (TLPH) United States $0.038B 0.00
Telomir Pharmaceuticals (TELO) United States $0.037B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
SCYNEXIS (SCYX) United States $0.031B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.030B 0.00
TherapeuticsMD (TXMD) United States $0.027B 0.00
Wellgistics Health (WGRX) United States $0.025B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.024B 0.00
Natural Alternatives (NAII) United States $0.022B 0.00
Jupiter Neurosciences (JUNS) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Phio Pharmaceuticals (PHIO) United States $0.018B 0.00
Scienture Holdings (SCNX) United States $0.018B 0.00
Klotho Neurosciences (KLTO) United States $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
Traws Pharma (TRAW) United States $0.015B 0.02
Iterum Therapeutics (ITRM) Ireland $0.015B 0.00
Vyome Holdings (HIND) United States $0.015B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.014B 0.00
Mannatech (MTEX) United States $0.014B 0.00
BioLineRx (BLRX) Israel $0.013B 0.00
Liminatus Pharma (LIMN) United States $0.012B 0.00
Tempest Therapeutics (TPST) United States $0.012B 0.00
CASI Pharmaceuticals (CASI) China $0.010B 0.00
Inotiv (NOTV) United States $0.010B 0.00
BioVie (BIVI) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
Ainos (AIMD) United States $0.007B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.007B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.006B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Ernexa Therapeutics (ERNA) United States $0.003B 0.00
China SXT Pharmaceuticals (SXTC) China $0.003B 0.00
Lyra Therapeutics (LYRA) United States $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
CDT Equity (CDT) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
PainReform (PRFX) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00